US President Donald Trump denied on Thursday that he was desperate for a deal with Iran, swinging between threats and diplomacy, while presenting a series of “boats of oil” that reportedly made it through the blocked Strait of Hormuz as an Iranian “gift” – a reveal that he teased a day earlier. This comes as the war he and Israel launched against Iran approaches the one-month mark with little end ...
US President Donald Trump denied on Thursday that he was desperate for a deal with Iran, swinging between threats and diplomacy, while presenting a series of “boats of oil” that reportedly made it through the blocked Strait of Hormuz as an Iranian “gift” – a reveal that he teased a day earlier. This comes as the war he and Israel launched against Iran approaches the one-month mark with little end in sight, driving oil prices up globally and further unsettling the global economy. “I read a story...
The Republic of Ireland were riding a wave of confidence into the World Cup playoff semi-final, according to Séamus Coleman, but it struck a rock on an agonising night in Prague. Heimir Hallgrímsson’s side squandered the initiative twice against the Czech Republic, in normal time and in the penalty shootout, as their hopes of qualifying for a first World Cup in 24 years evaporated. Ireland led 2-0...
The Republic of Ireland were riding a wave of confidence into the World Cup playoff semi-final, according to Séamus Coleman, but it struck a rock on an agonising night in Prague. Heimir Hallgrímsson’s side squandered the initiative twice against the Czech Republic, in normal time and in the penalty shootout, as their hopes of qualifying for a first World Cup in 24 years evaporated. Ireland led 2-0 after 23 minutes courtesy of a Troy Parrott penalty and a calamitous own goal by Czech goalkeeper Matej Kovar but they gifted the hosts a route back when Ryan Manning conceded a needless spot-kick. An 86th-minute equaliser from Wolves defender Ladislav Krejci took the game into extra time and then on to penalties. Continue reading...
Earnings Call Insights: IRIDEX Corporation (IRIX) Q4 2025 Management View Patrick Mercer, CEO, highlighted a year of "successful transformation" for IRIDEX, emphasizing that "we achieved our goals to streamline our operations, reduce costs and put IRIDEX on a path to sustainable profitability." Mercer reported full-year revenue of $52.7 million, reflecting 8% growth year-over-year, and noted "posi...
Earnings Call Insights: IRIDEX Corporation (IRIX) Q4 2025 Management View Patrick Mercer, CEO, highlighted a year of "successful transformation" for IRIDEX, emphasizing that "we achieved our goals to streamline our operations, reduce costs and put IRIDEX on a path to sustainable profitability." Mercer reported full-year revenue of $52.7 million, reflecting 8% growth year-over-year, and noted "positive adjusted EBITDA for the first time in the company's recent history" along with positive cash flow from operations in Q4. Mercer detailed ongoing cost-saving initiatives, including the relocation of certain G&A functions out of California for an expected $165,000 in quarterly savings starting Q1 2026, and a planned headquarters relocation later in 2026 to reduce the annual fixed cost base by approximately $600,000. He also shared that IRIDEX is "in active discussions with contract manufacturers as part of a multiyear initiative to transition production away from our Mountain View facilities," with full implementation expected in 2027. Key commercial results included strong Q4 growth in the glaucoma business, supported by the Cyclo G6 platform and the MedScout sales enablement software. The company sold 15,900 probes and 44 G6 systems in Q4, with full-year probe sales at 57,800 and system sales at 133. International glaucoma sales showed strength in Europe, Middle East, and Africa, though the conflict in Iran is materially impacting Middle East revenue. For the retina portfolio, Mercer stated that "PASCAL is firmly established as our flagship system," with a trend of upgrades and adoption among new ophthalmologists. The surgical retina segment "exceeded the plan for the quarter." International retina growth was described as solid, with some softness in the Middle East and Asia due to macroeconomic and geopolitical factors. Mercer highlighted nearly $1 million in business generated from leads at the American Academy of Ophthalmology Annual Meeting. CFO Romeo Dizon stated,...
Earnings Call Insights: Daré Bioscience (DARE) Q4 2025 Management View CEO Sabrina Johnson emphasized, "2026 is the year investors get to see what 10 years of that commitment actually looks like," highlighting the company's exclusive focus on women's health and the comprehensive pipeline. Johnson announced that DARE to PLAY, a topical sildenafil cream for female sexual arousal, began pre-fulfillme...
Earnings Call Insights: Daré Bioscience (DARE) Q4 2025 Management View CEO Sabrina Johnson emphasized, "2026 is the year investors get to see what 10 years of that commitment actually looks like," highlighting the company's exclusive focus on women's health and the comprehensive pipeline. Johnson announced that DARE to PLAY, a topical sildenafil cream for female sexual arousal, began pre-fulfillment prescribing in February 2026 and is now available in all 50 states, with telehealth access launched simultaneously. She stated, "DARE to PLAY is the only formulation that's backed by published clinical studies...manufactured in accordance with FDA's current good manufacturing practice regulations." Johnson described a digitally native commercial model, with Medvantx handling fulfillment and dispensing, and noted the strategy includes layering in distribution partnerships "from a position of leverage, not dependency and that's the playbook for a capital-efficient, strategically sequenced launch that we believe will maximize value for shareholders." Additional product launches were outlined: DARE to RESTORE Flora Sync LF5, a vaginal probiotic, is expected to become commercially available in Q2 2026, and DARE to RECLAIM, a bioidentical hormone therapy ring, targets 503B prescription fulfillment in 2027. Johnson explained, "DARE to RECLAIM is designed to be the first monthly intravaginal delivery solution in this space that includes both bioidentical estradiol and bioidentical progesterone together in 1 product." Johnson stated that Ovaprene's Phase III trial is on track to complete enrollment in 2026, with a data readout in 2027, and announced that DARE-HPV is advancing to Phase II with ARPA-H funding following IND clearance in February 2026. Chief Accounting Officer MarDee Haring-Layton reported, "We ended the year with approximately $24.7 million in cash and cash equivalents and working capital of approximately $3.4 million." Haring-Layton also stated, "We expect to begin...
Earnings Call Insights: Laird Superfood (LSF) Q4 2025 Management View Jason Vieth, President and CEO, stated that "Fiscal 2025 was a pivotal and transformative year for Laird Superfood. We delivered record net sales of $49.9 million, up 15% versus the prior year and in line with our revised guidance. In the fourth quarter alone, net sales rose 15% to $13.3 million." Vieth highlighted that wholesal...
Earnings Call Insights: Laird Superfood (LSF) Q4 2025 Management View Jason Vieth, President and CEO, stated that "Fiscal 2025 was a pivotal and transformative year for Laird Superfood. We delivered record net sales of $49.9 million, up 15% versus the prior year and in line with our revised guidance. In the fourth quarter alone, net sales rose 15% to $13.3 million." Vieth highlighted that wholesale channel sales surged more than 40% in both Q4 and for the full year, attributing the momentum to distribution expansion and strong velocities in grocery and club outlets. Vieth announced the successful relaunch of the company’s refrigerated creamers in late Q4 into early Q1, noting strong momentum in recent weeks and emphasizing improvements in product formulation and packaging. The CEO revealed the March 12 acquisition of Navitas Organics, funded by a $50 million investment from Nexus Capital, stating, "This transaction is perfectly on strategy and represents a major step in our vision of building a scaled Superfood platform." He explained that Nexus' preferred equity investment results in approximately 56.2% stake on an as-converted basis, with an option for an additional $60 million for future acquisitions or growth initiatives. Vieth outlined that the strategic focus remains on building scale, broadening the product portfolio, and creating a category leader with sustainable, profitable growth. Anya Hamill, Chief Financial Officer, confirmed, "We closed the year with record net sales of $49.9 million, which was up 15% year-over-year and Q4 net sales of $13.3 million, also up 15% versus prior year." Hamill added, "Our wholesale channel was the primary growth driver, increasing 44% year-over-year to $7.0 million in the fourth quarter and representing 52% of total Q4 net sales." Outlook Hamill stated, "While we are not providing detailed formal guidance for fiscal year 2026 at this time, I do want to share our directional expectations for the combined business." Managemen...
Earnings Call Insights: CapsoVision (CV) Q4 2025 Management View Kang Wang, Co-Founder, President, CEO & Director, stated that CapsoVision closed 2025 with increased commercial momentum for CapsoCam Plus, reporting "approximately 15% year-over-year revenue growth and 21% in new account generation, reflecting continued adoption of CapsoCam Plus across both new and existing customers." Wang emphasiz...
Earnings Call Insights: CapsoVision (CV) Q4 2025 Management View Kang Wang, Co-Founder, President, CEO & Director, stated that CapsoVision closed 2025 with increased commercial momentum for CapsoCam Plus, reporting "approximately 15% year-over-year revenue growth and 21% in new account generation, reflecting continued adoption of CapsoCam Plus across both new and existing customers." Wang emphasized the company's platform, noting "a wire-free capsule with unparalleled features, including 360-degree panoramic imaging on both storage and a fully cloud-based workflow that eliminates the need for external hardware worn on patient's body or on-site computing infrastructure." Wang highlighted a strategic shift in the CapsoCam Colon program, reporting, "we have refined our development strategy to prioritize our second-generation capsule." He explained, "we see a clear opportunity to advance directly to a more capable system that incorporates improved imaging performance, expanded field of view and enhanced AI functionality." Wang announced the company expects to submit a "510(k) application for CapsoCam Colon Gen 2 and its AI module in the third quarter of 2026." On the CapsoCam UGI and pancreatic cancer initiative, Wang stated, "we are pioneering a novel visual assessment method for the detection of pancreatic cancer," and that a clinical study "expected to begin in the second quarter of 2026" would enroll "approximately 60-90 patients." Wang reported a strengthened balance sheet, stating, "we recently strengthened our balance sheet with the completion of a $14 million private placement with participation from both new and existing investors." David Garcia, SVP of Finance, reported, "For the fourth quarter of 2025, total revenue was $3.9 million, reflecting 13% growth compared to the fourth quarter of 2024." Garcia also noted, "Gross profit was $2 million, an increase of $200,000 or 13% compared to the fourth quarter of 2024. Gross margin was 50% for the quarter, consiste...
Two years to the day since penalty shootout heartbreak against Poland, more agony from 12 yards for Wales. Bosnia and Herzegovina prevailed on spot-kicks after a typically absorbing night in the Welsh capital, one that went the distance, more than 133 minutes passed before Brennan Johnson spooned over and Neco Williams saw his penalty saved by Nikola Vasilj, who read Williams’s effort to his left....
Two years to the day since penalty shootout heartbreak against Poland, more agony from 12 yards for Wales. Bosnia and Herzegovina prevailed on spot-kicks after a typically absorbing night in the Welsh capital, one that went the distance, more than 133 minutes passed before Brennan Johnson spooned over and Neco Williams saw his penalty saved by Nikola Vasilj, who read Williams’s effort to his left. For so long it had seemed Daniel James, whose spot-kick was saved by Wojciech Szczesny to kill hopes of reaching Euro 2024, would be the match-winner but Edin Dzeko, who turned 40 this month, glanced in a header to take the game to extra time. For the second successive qualifying campaign, the locals left the Cardiff City Stadium with that horrible feeling in the pits of their stomachs, a numbness. Continue reading...
cherdchai chawienghong/iStock via Getty Images Introduction It’s been almost two years since I decided to cover Immersion Corporation ( IMMR ), and the decline of its share price prompted me to look into it once again and give some color on what has happened since then and why such a decline has occurred. Currently, there are a lot of risks around the restatement delays, which could push the compa...
cherdchai chawienghong/iStock via Getty Images Introduction It’s been almost two years since I decided to cover Immersion Corporation ( IMMR ), and the decline of its share price prompted me to look into it once again and give some color on what has happened since then and why such a decline has occurred. Currently, there are a lot of risks around the restatement delays, which could push the company to be delisted. Besides that, the company’s lumpy revenue business model and how they go about getting that revenue are still unappealing to me. I hope that the current investors or potential investors will weigh their relationship with IMMR and decide what is best for their money. The Beginning Of Troubles - BNED Accounting Issues It seems that the issues were identified in 2025. Immersion and Barnes & Noble ( BNED ) audit committee investigations found some accounting issues, which led to a lot of filings being in need of restatement. The core issues at hand were found to be unsupported manual journal entries that seem to have reduced the cost of sales in the fiscal 2024 and 2025 periods and errors in revenue recognition for the First Day Complete program. The revenue under this program was recognized too early because opt-out assumptions were incorrect and later were reversed when the actual opt-out rates were known. The full explanation can be found in the link here. Here is an excerpt: The Investigation is now complete and, based on the Investigation, the Barnes & Noble Education Audit Committee concluded that a former Barnes & Noble Education Payment Processing employee (whom Barnes & Noble Education had terminated) made unsupported manual journal entries that improperly reduced cost of sales in the fiscal years ended April 27, 2024 and May 3, 2025. And; The Investigation also concluded that certain revenue recognized in the third quarter of fiscal 2025 related to First Day Complete was incorrectly accelerated based upon incorrect optout assumptions; this revenue a...
Earnings Call Insights: Shoe Carnival (SCVL) Q4 2025 Management View Interim President & CEO Clifton Sifford opened by addressing the departure of former CEO Mark Worden on February 24 and confirmed his own appointment as Interim CEO, stating the search for a permanent successor is underway. Sifford emphasized his experience with the company and a focus on operational discipline, noting "Fiscal '2...
Earnings Call Insights: Shoe Carnival (SCVL) Q4 2025 Management View Interim President & CEO Clifton Sifford opened by addressing the departure of former CEO Mark Worden on February 24 and confirmed his own appointment as Interim CEO, stating the search for a permanent successor is underway. Sifford emphasized his experience with the company and a focus on operational discipline, noting "Fiscal '25 demonstrated this organization's fundamental operational discipline. Full year EPS of $1.90 exceeded consensus. Gross profit margin exceeded 35% for the fifth consecutive year. We ended the year debt-free for the 21st consecutive year with over $130 million in cash and securities." Sifford discussed the strategic adjustment in the rebanner program, sharing that 101 rebanners were completed in fiscal 2025, but observed "meaningful variability in in-store sales performance across the converted locations." He announced a slower pace with only 21 stores to be rebannered before back-to-school 2026 and reaffirmed the Board's commitment to Shoe Station as the company's long-term growth vehicle. The company launched the Jordan brand from Nike in over 60% of stores, with plans for a full fleet rollout by mid-April and a projected impact of approximately 5% of enterprise-level athletic sales. Sifford outlined three operational priorities for fiscal 2026: reducing inventory, completing targeted rebanners, and controlling costs, with an emphasis on working down $440 million in merchandise inventory. CFO W. Jackson stated, "Net sales in the fourth quarter were $254.1 million, a decline of 3.4% versus $262.9 million in the fourth quarter of fiscal 2024. Comparable store sales declined 3.5%. By banner, Shoe Station net sales were approximately flat with a low single-digit comparable store sales decline. Shoe Carnival net sales declined 4.5% with a mid-single-digit comparable store sales decline." Outlook Fiscal 2026 guidance includes expected net sales down 1% to up 1% versus fiscal 202...
Micron Technology (NASDAQ:MU), manufactures DRAM, flash memory, and SSDs, closed Thursday at $355.46, down 6.97%. The stock fell after analyst downgrades, AI compression-technology worries, and concerns about earnings quality, while investors are watching AI-memory demand, margin
Micron Technology (NASDAQ:MU), manufactures DRAM, flash memory, and SSDs, closed Thursday at $355.46, down 6.97%. The stock fell after analyst downgrades, AI compression-technology worries, and concerns about earnings quality, while investors are watching AI-memory demand, margin
Stock Market Today, March 26: Micron Technology Slides as Analysts Shift Toward GPU Names and Earnings Concerns Grow Yahoo Finance Here's Why Micron Stock Fell 12% This Week The Motley Fool How Much Further Could Micron Stock Fall? The Motley Fool
Stock Market Today, March 26: Micron Technology Slides as Analysts Shift Toward GPU Names and Earnings Concerns Grow Yahoo Finance Here's Why Micron Stock Fell 12% This Week The Motley Fool How Much Further Could Micron Stock Fall? The Motley Fool
To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of ...
To accommodate future growth of its Nashville workforce, Oracle has signed a new 116,000 square foot lease within The Neuhoff District, at 1320 Adams Street. With this latest investment, Oracle will bring its office capacity in Nashville to about 2,000 seats across three locations, marking significant progress in the company's plans to create thousands of new tech jobs and become a cornerstone of the local economy.
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Barclays head of US equity strategy & global equity linked strategies Venu Krishna, Goldman Sachs co-head health care business unit David Roman, Hartree Partners senior advisor and commodities analyst Ed Morse, GenTrust head o...
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Barclays head of US equity strategy & global equity linked strategies Venu Krishna, Goldman Sachs co-head health care business unit David Roman, Hartree Partners senior advisor and commodities analyst Ed Morse, GenTrust head of NY office and senior client advisor Mimi Duff, New York State Comptroller Thomas P. DiNapoli, Citi US equity strategist and global head of ETF research Scott Chronert, Morgan Stanley institute deputy global head of research and co-director Michael Zezas. (Source: Bloomberg)
Federal Reserve Governor Lisa Cook says the Iran war has shifted the balance of risks for now, leaving inflation as a bigger concern for policymakers than employment. She speaks during an event in New Haven, Connecticut. (Source: Bloomberg)
Federal Reserve Governor Lisa Cook says the Iran war has shifted the balance of risks for now, leaving inflation as a bigger concern for policymakers than employment. She speaks during an event in New Haven, Connecticut. (Source: Bloomberg)